Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relamorelin in diabetic gastroparesis
2017-002136-16Phase 3Terminated
- Sponsor
- Allergan
- Start
- Aug 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of relamorelin in diabetic gastroparesis, sponsored by Allergan. Started Aug 2018; status: terminated.
02
Drugs
relamorelin
03
Conditions
diabetic gastroparesis
Beyond the preview
Go deeper on 2017-002136-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002136-16.